105 related articles for article (PubMed ID: 10731974)
21. Evaluating the efficacy and toxicity of dose adjusted pegylated L-asparaginase in combination with therapeutic drug monitoring.
Coe-Eisenberg TD; Perissinotti AJ; Marini BL; Pettit KM; Bixby DL; Burke PW; Benitez L
Ann Hematol; 2023 Nov; 102(11):3133-3141. PubMed ID: 37480389
[TBL] [Abstract][Full Text] [Related]
22. Neurosurgical management of L-asparaginase induced haemorrhagic stroke.
Ogbodo E; Kaliaperumal C; O'Sullivan M
BMJ Case Rep; 2012 Mar; 2012():. PubMed ID: 22605598
[TBL] [Abstract][Full Text] [Related]
23. Experience with Generic Pegylated L-asparaginase in Children with Acute Lymphoblastic Leukemia from a Tertiary Care Oncology Center in South India.
Jayaraman D; Sneha LM; Jeyarani G; Somayajula A; Kothandam BT; Scott JX; Gadekar A
South Asian J Cancer; 2023 Oct; 12(4):371-377. PubMed ID: 38130281
[TBL] [Abstract][Full Text] [Related]
24. Acute pancreatitis following L-asparaginase in acute lymphoblastic leukemia.
M'harzi S; Elouali A; Lahrache K; Ghanam A; Babakhouya A; Rkain M; Benajiba N
Leuk Res Rep; 2022; 18():100357. PubMed ID: 36405565
[TBL] [Abstract][Full Text] [Related]
25. Allergic Reactions to E. coli Asparaginase are Associated with Decreased Asparaginase Activity in an Indonesian Pediatric Population with ALL.
Sari NM; Berbudi A; Susanah S; Reniarti L; Supriyadi E; Kaspers GJL; Buddington RK; Howard S; Idjradinata P
Asian Pac J Cancer Prev; 2023 Aug; 24(8):2773-2780. PubMed ID: 37642064
[TBL] [Abstract][Full Text] [Related]
26. Erythrocyte encapsulated l-asparaginase (GRASPA) in acute leukemia.
Thomas X; Le Jeune C
Int J Hematol Oncol; 2016 May; 5(1):11-25. PubMed ID: 30302200
[TBL] [Abstract][Full Text] [Related]
27. PKA inhibition kills L-asparaginase-resistant leukemic cells from relapsed acute lymphoblastic leukemia patients.
Lee JK; Wang X; Wang J; Rosales JL; Lee KY
Cell Death Discov; 2024 May; 10(1):257. PubMed ID: 38802344
[TBL] [Abstract][Full Text] [Related]
28. l-Asparaginase from
Khabade SP; Sirigiri DNR; Ram AB
ACS Omega; 2024 Jan; 9(3):3616-3624. PubMed ID: 38284052
[TBL] [Abstract][Full Text] [Related]
29. Re: Hydrocortisone to reduce dexamethasone-induced neurobehavioral side-effects in children with acute lymphoblastic leukaemia-results of a double-blind, randomised controlled trial with cross-over design.
Zhang D; Gu M
Eur J Cancer; 2023 Sep; 191():112979. PubMed ID: 37532597
[No Abstract] [Full Text] [Related]
30. Response to letter entitled: Re: Hydrocortisone to reduce dexamethasone-induced neurobehavioral side-effects in children with acute lymphoblastic leukaemia-results of a double-blind, randomised controlled trial with cross-over design.
van Hulst AM; Grootenhuis MA; van den Akker ELT; van den Heuvel-Eibrink MM
Eur J Cancer; 2023 Sep; 191():112980. PubMed ID: 37574396
[No Abstract] [Full Text] [Related]
31. [Hypertriglyceridemia, discovered on a pseudohyponatremia, induced by l-asparaginase in the treatment of B acute lymphoblastic leukemia in child].
Morand A; Barlogis V; Rouby F; Reynaud R; Marrec C; Michel G
Therapie; 2023; 78(5S):S91-S93. PubMed ID: 27771107
[No Abstract] [Full Text] [Related]
32. Alternative algorithm for L-asparaginase allergy in children with acute lymphoblastic leukemia.
Soyer OU; Aytac S; Tuncer A; Cetin M; Yetgin S; Sekerel BE
J Allergy Clin Immunol; 2009 Apr; 123(4):895-9. PubMed ID: 19081614
[TBL] [Abstract][Full Text] [Related]
33. Use of L-asparaginase in acute lymphoblastic leukemia: recommendations of the Polish Adult Leukemia Group.
Piatkowska-Jakubas B; Krawczyk-Kuliś M; Giebel S; Adamczyk-Cioch M; Czyz A; Lech Marańda E; Paluszewska M; Pałynyczko G; Piszcz J; Hołowiecki J;
Pol Arch Med Wewn; 2008 Nov; 118(11):664-9. PubMed ID: 19140571
[TBL] [Abstract][Full Text] [Related]
34. Prevention and management of antineoplastic-induced hypersensitivity reactions.
Zanotti KM; Markman M
Drug Saf; 2001; 24(10):767-79. PubMed ID: 11676304
[TBL] [Abstract][Full Text] [Related]
35. [New possibilities of treatment with PEG-L-asparaginase in patients with acute lymphoblastic leukemia sensitized to l-asparaginase E.coli and erwinase].
Sikorska-Fic B; Makowska K; Rokicka-Milewska R
Wiad Lek; 1998; 51 Suppl 4():233-6. PubMed ID: 10731974
[TBL] [Abstract][Full Text] [Related]
36. PEG-asparaginase allergy in children with acute lymphoblastic leukemia in the NOPHO ALL2008 protocol.
Henriksen LT; Harila-Saari A; Ruud E; Abrahamsson J; Pruunsild K; Vaitkeviciene G; Jónsson ÓG; Schmiegelow K; Heyman M; Schrøder H; Albertsen BK;
Pediatr Blood Cancer; 2015 Mar; 62(3):427-33. PubMed ID: 25418987
[TBL] [Abstract][Full Text] [Related]
37. Intravenous pegylated asparaginase versus intramuscular native Escherichia coli L-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a randomised, open-label phase 3 trial.
Place AE; Stevenson KE; Vrooman LM; Harris MH; Hunt SK; O'Brien JE; Supko JG; Asselin BL; Athale UH; Clavell LA; Cole PD; Kelly KM; Laverdiere C; Leclerc JM; Michon B; Schorin MA; Welch JJ; Lipshultz SE; Kutok JL; Blonquist TM; Neuberg DS; Sallan SE; Silverman LB
Lancet Oncol; 2015 Dec; 16(16):1677-90. PubMed ID: 26549586
[TBL] [Abstract][Full Text] [Related]
38. Outcomes Following Discontinuation of E. coli l-Asparaginase Upon Severe Allergic Reactions in Children With Acute Lymphoblastic Leukemia.
Yen HJ; Chang WH; Liu HC; Yeh TC; Hung GY; Wu KH; Peng CT; Chang YH; Chang TK; Hsiao CC; Sheen JM; Chao YH; Chang TT; Chiou SS; Lin PC; Wang SC; Lin MT; Ho WL; Chen YC; Liang DC
Pediatr Blood Cancer; 2016 Apr; 63(4):665-70. PubMed ID: 26703788
[TBL] [Abstract][Full Text] [Related]
39. Peg-asparaginase for acute lymphoblastic leukemia.
Rytting M
Expert Opin Biol Ther; 2010 May; 10(5):833-9. PubMed ID: 20345338
[TBL] [Abstract][Full Text] [Related]
40. Pegaspargase: an alternative?
Holle LM
Ann Pharmacother; 1997 May; 31(5):616-24. PubMed ID: 9161659
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
